[1]
|
Sectish, C.T. and Prober, C.G. (2007) Pneumonia. In: Kliegman, R.M., Behrman, R.E., Jenson, H.B. and Stanton, B.F., Eds., Nelson Text Book of Paediatrics, Saunders, New Delhi, 1795-1798.
|
[2]
|
Kabra, S.K., Lodha, R. and Pandy, R.M. (2010) Antibiotic for community acquired pneumonia in children. Cochrane Database of Systematic Reviews, 17.
doi:10.1002/14651858.CD004874.pub3
|
[3]
|
UNICEF/WHO (2013) Pneumonia: The forgotten killer of children.
http://www. who. int/ maternal_child_adolesc ent/documents/9 280640489/en/
|
[4]
|
Naheed, A., Saha, S.K., Breiman, R.F., Khatun, F., Brooks, W.A., Arifeen, S.E., et al. (2009) Multihospital surveillance of pneumonia burden among children aged <5 years hospitalized for pneumonia in Bangladesh. CID, 48, S82-S89. doi:10.1086/596485
|
[5]
|
Bradley, J.S., Arguedas, A., Blumer, J.L., Saéz-Llorens, X., Melkote, R. and Noel, G.J. (2007) Comparative study of levofloxacin in the treatment of children with community-acquired pneumonia. The Pediatric Infectious Disease Journal, 26, 868-878.
doi:10.1097/INF.0b013e3180cbd2c7
|
[6]
|
Chein, S., Wells, T.G., Blumer, J.L., Kearnset, G.L., Bradly, J.S., Bocchini, J.A., et al. (2005) Levofloxacin pharmacokinetic in children. The Journal of Clinical Pharmacology,45,153-160.doi:10. 1177/009 1270004271944
|
[7]
|
Rang, H.P., Dale, M.M., Ritter, J.M. and Flower, R.J. (2008) Rang and dale’s pharmacology. Churchill Livingstone Elsevier, New York, 660-678.
|
[8]
|
Pallares, R., Linares, J., Vadillo, M., Cabellos, C., Manresa, F., Viladrich, P.F., Martin, R. and Gudiol, F. (1995) Penicillin and cephalosporin and mortality from severe pneumococcal pneumonia in Barcelona. The New England Journal of Medicine, 333, 474-480.
doi:10.1056/NEJM199508243330802
|
[9]
|
WHO (2011) Fluroquinolones use in paediatrics: Focus on safety and place in therapy. 18th Expart Committee on the Selection and Use of Essential Medicines, Gneva, 1-13.
|
[10]
|
Bradly, J.A. (2013) Multicentre, randomized, open-label, comparative study to compare the efficacy and safety of levofloxacin and standard of care therapy in the treatment of children with community-acquired pneumonia in the hospitalized or outpatient setting.
http://filehosting.pharmacon.com
|
[11]
|
Chambers, H.F. and Deck, D.H. (2009) Sulfonamides, trimethoprim & quinolones. In: Katzung, B.G., Master, S.B. and Trevor, J.A., Eds., Basic and Clinical Pharmacology, Prentice-Hall International Inc., New Delhi, 815-822.
|
[12]
|
File, J.R., Segreti, J., Dunbar, L., Player, R., Kohler, R., Williams, R.R., et al. (1997) A multicentre, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia. Antimicrob Agents and Chemother, 41, 1965-1972.
|
[13]
|
Prescot, L.M. (2002) Highlights of the 41st interscience conference on antimicrobial agents and chemotherapy. Pharmacy & Therapeutics, 77, 143-146.
|